These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
154 related articles for article (PubMed ID: 34638032)
1. Cardamonin inhibits LPS-induced inflammatory responses and prevents acute lung injury by targeting myeloid differentiation factor 2. Yang L; Luo W; Zhang Q; Hong S; Wang Y; Samorodov AV; Chattipakorn N; Pavlov VN; Liang G Phytomedicine; 2021 Dec; 93():153785. PubMed ID: 34638032 [TBL] [Abstract][Full Text] [Related]
2. Flavokawain B alleviates LPS-induced acute lung injury via targeting myeloid differentiation factor 2. Luo W; Yang LB; Qian CC; Ma B; Manjengwa GM; Miao XM; Wang J; Hu CH; Jin B; Zhang LX; Zheng C; Liang G; Wang Y Acta Pharmacol Sin; 2022 Jul; 43(7):1758-1768. PubMed ID: 34737421 [TBL] [Abstract][Full Text] [Related]
3. Chalcone derivatives ameliorate lipopolysaccharide-induced acute lung injury and inflammation by targeting MD2. Zhang YL; Zhang WX; Yan JQ; Tang YL; Jia WJ; Xu ZW; Xu MJ; Chattipakorn N; Wang Y; Feng JP; Liu ZG; Liang G Acta Pharmacol Sin; 2022 Jan; 43(1):76-85. PubMed ID: 34480112 [TBL] [Abstract][Full Text] [Related]
4. Inhibition of myeloid differentiation factor 2 by baicalein protects against acute lung injury. Chen H; Zhang Y; Zhang W; Liu H; Sun C; Zhang B; Bai B; Wu D; Xiao Z; Lum H; Zhou J; Chen R; Liang G Phytomedicine; 2019 Oct; 63():152997. PubMed ID: 31254764 [TBL] [Abstract][Full Text] [Related]
5. Licochalcone A protects against LPS-induced inflammation and acute lung injury by directly binding with myeloid differentiation factor 2 (MD2). Zhu W; Wang M; Jin L; Yang B; Bai B; Mutsinze RN; Zuo W; Chattipakorn N; Huh JY; Liang G; Wang Y Br J Pharmacol; 2023 Apr; 180(8):1114-1131. PubMed ID: 36480410 [TBL] [Abstract][Full Text] [Related]
6. L6H9 attenuates LPS-induced acute lung injury in rats through targeting MD2. Wu P; Yan H; Qi J; Jia W; Zhang W; Yao D; Ding C; Zhang Y; Chen M; Cai X Drug Dev Res; 2020 Feb; 81(1):85-92. PubMed ID: 31693211 [TBL] [Abstract][Full Text] [Related]
7. Shikonin inhibits myeloid differentiation protein 2 to prevent LPS-induced acute lung injury. Zhang Y; Xu T; Pan Z; Ge X; Sun C; Lu C; Chen H; Xiao Z; Zhang B; Dai Y; Liang G Br J Pharmacol; 2018 Mar; 175(5):840-854. PubMed ID: 29243243 [TBL] [Abstract][Full Text] [Related]
8. Piperlongumine mitigates LPS-induced inflammation and lung injury via targeting MD2/TLR4. Tang Y; Zhang W; Wu L; Bai B; Zheng B; Li M; Tang Y; Zhu X; Zhang Y; Wang Y; Zhang B Biochem Biophys Res Commun; 2023 Jan; 642():118-127. PubMed ID: 36566563 [TBL] [Abstract][Full Text] [Related]
9. Targeting myeloid differentiation protein 2 by the new chalcone L2H21 protects LPS-induced acute lung injury. Zhang Y; Xu T; Wu B; Chen H; Pan Z; Huang Y; Mei L; Dai Y; Liu X; Shan X; Liang G J Cell Mol Med; 2017 Apr; 21(4):746-757. PubMed ID: 27860279 [TBL] [Abstract][Full Text] [Related]
10. Discovery of new MD2 inhibitor from chalcone derivatives with anti-inflammatory effects in LPS-induced acute lung injury. Zhang Y; Wu J; Ying S; Chen G; Wu B; Xu T; Liu Z; Liu X; Huang L; Shan X; Dai Y; Liang G Sci Rep; 2016 Apr; 6():25130. PubMed ID: 27118147 [TBL] [Abstract][Full Text] [Related]
11. Radix Glycyrrhizae extract and licochalcone a exert an anti-inflammatory action by direct suppression of toll like receptor 4. Cai M; Xu YC; Deng B; Chen JB; Chen TF; Zeng KF; Chen S; Deng SH; Tan ZB; Ding WJ; Zhang SW; Liu B; Zhang JZ J Ethnopharmacol; 2023 Feb; 302(Pt A):115869. PubMed ID: 36309116 [TBL] [Abstract][Full Text] [Related]
12. Daidzein attenuates lipopolysaccharide-induced acute lung injury via toll-like receptor 4/NF-kappaB pathway. Feng G; Sun B; Li TZ Int Immunopharmacol; 2015 Jun; 26(2):392-400. PubMed ID: 25887269 [TBL] [Abstract][Full Text] [Related]
13. Fucoxanthin attenuates LPS-induced acute lung injury via inhibition of the TLR4/MyD88 signaling axis. Li X; Huang R; Liu K; Li M; Luo H; Cui L; Huang L; Luo L Aging (Albany NY); 2020 Dec; 13(2):2655-2667. PubMed ID: 33323555 [TBL] [Abstract][Full Text] [Related]
14. Hyaluronan ameliorates LPS-induced acute lung injury in mice via Toll-like receptor (TLR) 4-dependent signaling pathways. Xu C; Chen G; Yang W; Xu Y; Xu Y; Huang X; Liu J; Feng Y; Xu Y; Liu B Int Immunopharmacol; 2015 Oct; 28(2):1050-8. PubMed ID: 26321117 [TBL] [Abstract][Full Text] [Related]
15. Mogroside IIIE Attenuates LPS-Induced Acute Lung Injury in Mice Partly Through Regulation of the TLR4/MAPK/NF-κB Axis via AMPK Activation. Tao L; Cao F; Xu G; Xie H; Zhang M; Zhang C Phytother Res; 2017 Jul; 31(7):1097-1106. PubMed ID: 28512854 [TBL] [Abstract][Full Text] [Related]
16. Protective effect of forsythoside B against lipopolysaccharide-induced acute lung injury by attenuating the TLR4/NF-κB pathway. Liu JX; Li X; Yan FG; Pan QJ; Yang C; Wu MY; Li G; Liu HF Int Immunopharmacol; 2019 Jan; 66():336-346. PubMed ID: 30521962 [TBL] [Abstract][Full Text] [Related]
17. Physalin B ameliorates inflammatory responses in lipopolysaccharide-induced acute lung injury mice by inhibiting NF-κB and NLRP3 via the activation of the PI3K/Akt pathway. Zhong R; Xia T; Wang Y; Ding Z; Li W; Chen Y; Peng M; Li C; Zhang H; Shu Z J Ethnopharmacol; 2022 Feb; 284():114777. PubMed ID: 34737012 [TBL] [Abstract][Full Text] [Related]
18. Protective effects of hesperetin on lipopolysaccharide-induced acute lung injury by targeting MD2. Ye J; Guan M; Lu Y; Zhang D; Li C; Li Y; Zhou C Eur J Pharmacol; 2019 Jun; 852():151-158. PubMed ID: 30807747 [TBL] [Abstract][Full Text] [Related]
19. Angiotensin II type 2 receptor agonist attenuates LPS-induced acute lung injury through modulating THP-1-derived macrophage reprogramming. Chen L; Gong P; Su Y; Meng L; Wang M; Gao W; Liu Q Naunyn Schmiedebergs Arch Pharmacol; 2024 Jan; 397(1):99-108. PubMed ID: 37368029 [TBL] [Abstract][Full Text] [Related]
20. Schisandrin B protects against LPS-induced inflammatory lung injury by targeting MyD88. Zhu W; Luo W; Han J; Zhang Q; Ji L; Samorodov AV; Pavlov VN; Zhuang Z; Yang D; Yin L; Huang L; Liang G; Huh JY; Wang Y Phytomedicine; 2023 Jan; 108():154489. PubMed ID: 36270224 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]